Date
|
Speaker
|
Title
|
Thursday
September 2
at NOON |
Eugene
Johnson, M.D.
Molecular Biology and Pharmacology
Washington University
School of Medicine
|
GFL
neurotrophic factors: discovery, functions and therapeutic potential. |
| September
7 |
TBA |
|
September
14 |
Dennis C. Liotta, Ph.D.
Professor of Chemistry
Emory University
|
Novel therapies
derived from low toxicity natural product leads. |
| September
21 |
Roland K. Strong,
Ph.D.
Fred Hutchinson Cancer Center
Structural Biology
Seattle, WA
|
Siderocalin,
siderophores and iron: a novel antibacterial innate immune defense
strategy. |
| September
28 |
No Seminar
|
|
October
5 at NOON
Storm Eye 8th Fl
Conference Room
|
Donald Fox, Ph.D.
Professor
Biology and Biochemistry
University of Houston
|
Transgenic and
pharmacological approaches for retinal neuroprotection: mitochondria
and mechanisms of apoptosis. |
| October
12 |
Leonard C. Erickson, Ph.D.
Deputy Director Indiana University Cancer Center
|
Inhibition of DNA repair to enhance chemotherapy. |
| October
19 |
Ching-Shih Chen,
Ph.D.
Professor
College of Pharmacy
Ohio State University
|
Targeting Akt
signaling in anticancer drug discovery. |
| October
26 |
Palmer W. Taylor,
Ph.D.
Professor and Trout
Chair
Pharmacology
University of California,
San Diego
|
Freeze-frame,
click chemistry approaches to drug design: studies with cholinergic
nervous system templates. |
| November
2 |
Alex Whitley
Ph.D. Student
Pharmacology
|
Epithelial
cell accumulation of the cancer preventative polyphenol ellagic
acid: Role of OAT transporters.
|
| November
9 |
Robert A. Roth,
Ph.D.
Pharmacology and Toxicology
University of Michigan
|
Inflammation
and hepatotoxicity: is there a relation to drug idiosyncrasy? |
| November
16 |
Richard A.
Gibbs, Ph.D.
Associate Professor
Medicinal Chemistry and Molecular Pharmacology
Purdue University
|
Combinational modulation
of protein prenylation. |
| November
23 |
Jin-ping Li,
Ph.D.
Biochemistry and Microbiology
Uppsala University
|
Structure and Function
of Heparan Sulfate |
| November
30 |
Billy Day, Ph.D.
Associate Professor
Pharmaceutical Sciences
University of Pittsburgh
|
Computational, synthetic
and pharmacological discovery of new microtubule perturbing agents. |
Thusday December
9 at 1:00 PM |
Rick Wagner,
Ph.D.
Professor
Medicinal Chemistry
University of Minnesota
|
Harnessing the
power of chemical biology: from drug design to nanobiotechnology. |
Friday December
17 at 3:00 PM in 2 West Amphitheater |
Ryan Monfeli
Ph.D. Student
|
Development of
inhibitors for the M. tuberculosis iron dependent regulator protein. |